The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Ohta, Shoichiro ^a   Okamoto, Masaki ^b,c   Fujimoto, Kiminori ^b   Sakamoto, Noriho ^d   Takahashi, Koichiro ^a   Yamamoto, Hiroshi ^e   Kushima, Hisako ^f   Ishii, Hiroshi ^f   Akasaka, Keiichi ^g   Ono, Junya ^h   Kamei, Ayami ^h   Azuma, Yoshinori ^h   Matsumoto, Hisako ⁱ   Yamaguchi, Yukie ^j   Aihara, Michiko ^j   Johkoh, Takeshi ^k   Kawaguchi, Atsushi ^a   Ichiki, Masao ^c   Sagara, Hironori ^g   Kadota, Jun Ichi ^f   Hanaoka, Masayuki ^e   Hayashi, Shinichiro ^a   Kohno, Shigeru ^d   Hoshino, Tomoaki ^b   Izuhara, Kenji ^a   more..

^a SAGA UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OITA UNIVERSITY   (Japan)

^g DOKKYO MEDICAL UNIVERSITY   (Japan)

^h SHINO TEST CORPORATION   (Japan)

ⁱ KYOTO UNIVERSITY   (Japan)

^j YOKOHAMA CITY UNIVERSITY   (Japan)

^k Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; KL 6 PROTEIN; LACTATE DEHYDROGENASE; SP D PROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; POSTN PROTEIN, HUMAN;

ADULT; ARTICLE; ASTHMA; ATOPIC DERMATITIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MULTICENTER STUDY; PREDICTION; PROTEIN DETERMINATION; PROTEIN FUNCTION; SYSTEMIC SCLEROSIS; AGED; ANIMAL; BLOOD; CELL LINE; CHEMISTRY; CLINICAL TRIAL; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; ANIMALS; BIOMARKERS; CELL ADHESION MOLECULES; CELL LINE; COHORT STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE;

EID: 85016443590     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0174547     Document Type: Article

References (39)

1. Ley B, Collard HR, King TE Jr., Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:431-40. https://doi.org/10.1164/rccm.201006-0894CI PMID: 20935110
2. Collard HR, King TE Jr., Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003;168:538-42. https://doi.org/10.1164/rccm.200211-1311OC PMID: 12773325
3. Zappala CJ, Latsi PI, Nicholson AG, Colby TV, Cramer D, Renzoni EA, et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J. 2010;35:830-6. https://doi.org/10.1183/09031936.00155108 PMID: 19840957
4. Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000;162:1109-14. https://doi.org/10.1164/ajrccm.162.3.9910080 PMID: 10988138
5. Greene KE, King TE Jr., Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS, et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J. 2002;19:439-46. PMID: 11936520
6. Yokoyama A, Kondo K, Nakajima M, Matsushima T, Takahashi T, Nishimura M, et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology. 2006;11:164-8. https://doi.org/10. 1111/j.1440-1843.2006.00834.x PMID: 16548901
7. Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012;185:67-76. https://doi.org/10.1164/rccm.201101-0058OC PMID: 22016448
8. Izuhara K, Conway SJ, Moore BB, Matsumoto H, Holweg C T J, Matthews JG, et al. Roles of periostin in respiratory disorders. Am J Respir Crit Care Med. 2016;193, 949-56. https://doi.org/10.1164/rccm. 201510-2032PP PMID: 26756066
9. Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, et al. The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci. 2014;71:1279-88. https://doi.org/10.1007/s00018-013-1494-y PMID: 24146092
10. Uchida M, Shiraishi H, Ohta S, Arima K, Taniguchi K, Suzuki S, et al. Periostin, a Matricellular Protein, Plays a Role in the Induction of Chemokines in Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2012;46:677-86. https://doi.org/10.1165/rcmb.2011-0115OC PMID: 22246863
11. Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Kawayama T, Fujimoto K, et al. Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias. Eur Respir J. 2011;37:1119-27. https://doi.org/10.1183/09031936.00059810 PMID: 21177844
12. Naik PK, Bozyk PD, Bentley JK, Popova AP, Birch CM, Wilke CA, et al. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012;303:L1046-56. https://doi.org/10.1152/ajplung.00139.2012 PMID: 23043074
13. Taniguchi K, Arima K, Masuoka M, Ohta S, Shiraishi H, Ontsuka K, et al. Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1á/IL-6 loop. J Invest Dermatol. 2014;134:1295-304. https://doi.org/10.1038/jid.2013.500 PMID: 24352037
14. Tajiri M, Okamoto M, Fujimoto K, Johkoh T, Ono J, Tominaga M, et al. Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis. Respir Investig. 2015;53:73-81. https://doi.org/10.1016/j.resinv. 2014.12.003 PMID: 25745852
15. Izuhara K, Arima K, Ohta S, Suzuki S, Inamitsu M, Yamamoto K. Periostin in allergic inflammation. Allergology Int. 2014;63:143-51.
16. Nance T, Smith KS, Anaya V, Richardson R, Ho L, Pala M, et al. Transcriptome analysis reveals differential splicing events in IPF lung tissue. PLOS ONE. 2014;9:e92111. https://doi.org/10.1371/journal. pone.0092111 PMID: 24647608
17. Takayama G, Arima K, Kanaji T, Toda S, Tanaka H, Shoji S, et al. Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy Clin Immunol. 2006;118:98-104. https://doi.org/10.1016/j.jaci.2006.02.046 PMID: 16815144
18. Ohta S, Shibata R, Nakao Y, Azuma Y, Taniguchi K, Arima K, et al. The usefulness of combined measurements of squamous cell carcinoma antigens 1 and 2 in diagnosing atopic dermatitis. Ann Clin Biochem. 2012;49:277-84. https://doi.org/10.1258/acb.2011.011065 PMID: 22402915
19. Travis WD, Costabel U, Hansell DM, King TE Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733-48. https://doi.org/10.1164/rccm.201308-1483ST PMID: 24032382
20. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824. https://doi.org/10.1164/rccm.2009-040GL PMID: 21471066
21. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr., et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007;176:636-43. https://doi.org/10.1164/rccm.200703-463PP PMID: 17585107
22. Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med. 2008;177:433-9. https://doi.org/10.1164/rccm.200611-1696OC PMID: 17975197
23. Fujimoto K, Taniguchi H, Johkoh T, Kondoh Y, Ichikado K, Sumikawa H, et al. Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality. Eur Radiol. 2012;22:83-92. https://doi.org/10.1007/s00330-011-2211-6 PMID: 21822949
24. Kou K, Okawa T, Yamaguchi Y, Ono J, Inoue Y, Kohno M, et al. Periostin levels correlate disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol. 2014;171:283-91. https://doi.org/10.1111/bjd.12943 PMID: 24601864
25. Yamaguchi Y, Ono J, Masuoka M, Ohta S, Izuhara K, Ikezawa Z, et al. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermatol. 2013;168:717
26. https://doi.org/10.1111/bjd.12117 PMID: 23110679
27. Nagasaki T, Matsumoto H, Kanemitsu Y, Izuhara K, Tohda Y, Horiguchi T, et al. Using exhaled nitric oxide and serum periostin as a composite marker to identify severe/steroid-insensitive asthma. Am J Respir Crit Care Med. 2014;190:1449-52. https://doi.org/10.1164/rccm.201407-1290LE PMID: 25496105
28. Kii I, Nishiyama T, Li M, Matsumoto K, Saito M, Amizuka N, et al. Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture. J Biol Chem. 2010;285:2028-39. https://doi.org/10.1074/jbc. M109.051961 PMID: 19887451
29. Didangelos A, Yin X, Mandal K, Saje A, Smith A, Xu Q, et al. Extracellular matrix composition and remodeling in human abdominal aortic aneurysms: a proteomics approach. Mol Cell Proteomics. 2011;10:M111.008128.
30. Ward PA. Oxidative stress: acute and progressive lung injury. Ann N Y Acad Sci. 2010;1203:53-9. https://doi.org/10.1111/j.1749-6632.2010.05552.x PMID: 20716283
31. Hecker L, Cheng J, Thannickal VJ. Targeting NOX enzymes in pulmonary fibrosis. Cell Mol Life Sci. 2012;69:2365-71. https://doi.org/10.1007/s00018-012-1012-7 PMID: 22618245
32. van den Blink B, Wijsenbeek MS, Hoogsteden HC. Serum biomarkers in idiopathic pulmonary fibrosis. Pulm Pharmacol Ther. 2010;23:515-20. https://doi.org/10.1016/j.pupt.2010.08.001 PMID: 20708704
33. Borensztajn K, Crestani B, Kolb M. Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers-insights from the bench side. Respiration. 2013;86:441-52. https://doi.org/10.1159/000357598 PMID: 24356558
34. Litvin J, Selim AH, Montgomery MO, Lehmann K, Rico MC, Devlin H, et al. Expression and function of periostin-isoforms in bone. Journal of cellular biochemistry. 2004;92:1044-61. https://doi.org/10.1002/jcb.20115 PMID: 15258926
35. Yamada S, Tauchi T, Awata T, Maeda K, Kajikawa T, Yanagita M, et al. Characterization of a novel periodontal ligament-specific periostin isoform. Journal of dental research. 2014;93:891-7. https://doi.org/10.1177/0022034514543015 PMID: 25012810
36. Morra L, Rechsteiner M, Casagrande S, von Teichman A, Schraml P, Moch H, et al. Characterization of periostin isoform pattern in non-small cell lung cancer. Lung cancer. 2012;76:183-90. https://doi.org/10.1016/j.lungcan. 2011.10.013 PMID: 22079858
37. Morra L, Rechsteiner M, Casagrande S, Duc Luu V, Santimaria R, Diener PA, et al. Relevance of periostin splice variants in renal cell carcinoma. Am J Pathol. 2011;179:1513-21. https://doi.org/10.1016/j. ajpath.2011.05.035 PMID: 21763681
38. King TE Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2083-92. https://doi.org/10.1056/NEJMoa1402582 PMID: 24836312
39. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370:2071-82. https://doi.org/10.1056/NEJMoa1402584 PMID: 24836310